PHARMACOKINETICS (PK) AND SAFETY OF GLASDEGIB IN PARTICIPANTS WITH MODERATE AND SEVERE HEPATIC IMPAIRMENT: A PHASE 1, OPEN-LABEL, SINGLE-DOSE, PARALLEL-GROUP STUDY.
CLINICAL PHARMACOLOGY & THERAPEUTICS（2020）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined